| Financial Year |
March 31 2023 |
| Monetary Funds |
770,132,539.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
48,074,894.44 |
| Advances to Suppliers |
24,796,863.47 |
| Other Receivables |
306,787,168.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,567,027,043.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
615,411,355.28 |
| Total Current Assets |
6,334,494,954.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
30,487,254.56 |
| Long-term Equity Investment |
131,922,822.87 |
| Investment Properties |
27,740,234.74 |
| Fixed Assetes |
138,330,510.84 |
| Under-construction Projects |
5,260,453.69 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
98,776,801.74 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,976,611.25 |
| Deferred Income Tax Assets |
171,774,308.39 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
606,268,998.08 |
| Total Assets |
6,940,763,952.25 |
| Short-Term Loans |
62,970,611.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
110,538,561.42 |
| Accounts Payable |
1,124,373,407.60 |
| Accounts Received In Advance |
24,635,837.84 |
| Employee Compensation Payable |
10,086,327.87 |
| Taxes Payable |
128,823,043.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
549,297,644.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
288,445,745.69 |
| Other Current Liabilities |
197,774,777.89 |
| Sub-Total of Current Liabilities |
5,142,192,580.47 |
| Long-term Loans |
559,853,722.02 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,974,205.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
641,941,348.99 |
| Total Liabilities |
5,784,133,929.46 |
| Paid-In Capital(Or Share Stock) |
1,100,462,170.00 |
| Capital Surplus |
248,347,989.47 |
| Surplus Reserve |
41,308,189.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-427,893,997.47 |
| Minority Stockholder's Interest |
194,404,589.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
962,225,433.38 |
| Owner's Equity（Stockholder's Equity） |
1,156,630,022.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,940,763,952.25 |
